Commentary Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/autoimmune.1.005
Cxcl17 and its association with T cells
Marcela Hernández-Ruiz1, Albert Zlotnik2,*
- 1Lymphotrek, San Diego, CA, United States
- 2Department of Physiology and Biophysics and Institute for Immunology, University of California Irvine, Irvine, CA, United States
Corresponding Author
Albert Zlotnik, azlotnik@uci.edu
Received Date: September 02, 2020
Accepted Date: September 23, 2020
Hernández-Ruiz M, Zlotnik A. Cxcl17 and its association with T cells. Arch Autoimmune Dis 2020; 1(1):28-31.
Copyright: © 2020 Hernández-Ruiz M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
CXCL17, Auto immunities, T cells, IL-23
Recommended Articles
Cxcl17 and its association with T cells
We recently published an article describing the importance of CXCL17 in T cell responses [1]. In summary, we observed the following:
1) Cxcl17 is necessary to maintain normal ratios of T cell subpopulations in lymph nodes (LN).
2) Cxcl17-/- mice develop more intense inflammatory responses than wild type mice.
CD4+Foxp3+Helios+regulatory T cells: Role in immunostasis and clinical applications
Since Gershon and Kondo’s initial description of suppressor T cells as antigen-specific T cells that regulate immune responses [1], several advances have taken place on the biology and potential applications of regulatory T cells (Tregs) in clinical settings. After that, Sakaguchi et al. identified Treg cells capable of protecting lymphopenic mice against autoimmune disease produced by neonatal thymectomy [2], and Morrissey et al.
Inhibiting hypoxia-inducible factor in T cells strengthens effector-memory function in CD8+ T cells
In a recent attempt to elucidate the role of HIF1α in modulating the fate of T cells, we have demonstrated that the targeted deletion of HIF1α, specifically in T cells, enhances the inflammatory capabilities and memory phenotype of CD8+ T cells. These findings validate that the T cell-specific ablation of HIF1α or pharmacological inhibition of HIF1α reduces the development of B16F10 melanomas, suggesting an improved anti-tumor immune response characterized by improved secretion of effector molecules, such as IFN-γ, granzyme B, and TNFα, in the CD8+ T cells. Thus, it appears that HIF1α might negatively influence specific effector functions of CD8+ T cells, which are crucial for destroying and targeting tumor cells.
The interplay of regulatory T cells, endoplasmic reticulum stress, and unfolded protein response activation in post-transplant alloimmune hepatitis and autoimmune hepatitis
The incidence and prevalence of autoimmune hepatitis (AIH) globally is 1.28 per 100,000 population-years (95% CI, 1.01-1.63) and 15.65 per 100,000 population (95% CI, 13.42-18.24), respectively [1]. The incidence and prevalence in children is 0.4 and 3.0 cases per 100,000 children [2], and in adults 17 per 100,000 [3,4].
The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy
Originally identified for its involvement in phosphorylating glycogen synthase and regulating glucose metabolism in response to insulin, glycogen synthase kinase-3 (GSK-3) has since been recognized as a versatile serine/threonine kinase with diverse functions [1,2]. Extensive research has demonstrated that GSK-3 phosphorylates over 100 protein substrates where it intersects numerous signaling pathways. While it was initially implicated in the regulation of glucose metabolism, subsequent investigations revealed an impact of GSK-3 in cellular processes beyond glycogen synthase phosphorylation and glycogen metabolism [3].